- Home
- ICCC vs JZXN Comparison
ICCC vs JZXN Comparison
Compare ICCC & JZXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCC
- JZXN
- Stock Information
- Founded
- ICCC 1982
- JZXN 2019
- Country
- ICCC United States
- JZXN China
- Employees
- ICCC N/A
- JZXN N/A
- Industry
- ICCC Biotechnology: Pharmaceutical Preparations
- JZXN Retail-Auto Dealers and Gas Stations
- Sector
- ICCC Health Care
- JZXN Consumer Discretionary
- Exchange
- ICCC Nasdaq
- JZXN Nasdaq
- Market Cap
- ICCC 60.1M
- JZXN 51.8M
- IPO Year
- ICCC 1987
- JZXN 2021
- Fundamental
- Price
- ICCC $5.92
- JZXN $1.03
- Analyst Decision
- ICCC
- JZXN
- Analyst Count
- ICCC 0
- JZXN 0
- Target Price
- ICCC N/A
- JZXN N/A
- AVG Volume (30 Days)
- ICCC 7.7K
- JZXN 256.3K
- Earning Date
- ICCC 11-12-2025
- JZXN 03-05-2026
- Dividend Yield
- ICCC N/A
- JZXN N/A
- EPS Growth
- ICCC N/A
- JZXN N/A
- EPS
- ICCC 0.20
- JZXN N/A
- Revenue
- ICCC $28,274,756.00
- JZXN $97,465.00
- Revenue This Year
- ICCC N/A
- JZXN N/A
- Revenue Next Year
- ICCC N/A
- JZXN N/A
- P/E Ratio
- ICCC $30.55
- JZXN N/A
- Revenue Growth
- ICCC 21.75
- JZXN N/A
- 52 Week Low
- ICCC $3.34
- JZXN $0.78
- 52 Week High
- ICCC $7.60
- JZXN $7.82
- Technical
- Relative Strength Index (RSI)
- ICCC 41.72
- JZXN 58.00
- Support Level
- ICCC $6.29
- JZXN $0.78
- Resistance Level
- ICCC $6.42
- JZXN $1.12
- Average True Range (ATR)
- ICCC 0.24
- JZXN 0.07
- MACD
- ICCC -0.02
- JZXN 0.04
- Stochastic Oscillator
- ICCC 1.82
- JZXN 73.53
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About JZXN Jiuzi Holdings Inc.
Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It sells new energy vehicles in third-fourth tier cities in China. The firm also sells plug-in electric vehicles on demand from vehicle buyers. Its operating segments are propretaey product; and resale of sourced Equipment and accessories from third party products. The company generates a majority of its revenue from the propretaey product segment. Geographically, the firm operates in China.